| scholarly article | Q13442814 |
| P2093 | author name string | David S Wang | |
| Daniel Y Sze | |||
| John D Louie | |||
| P2860 | cites work | Global cancer statistics | Q22241238 |
| A prospective evaluation of treatment with Selective Internal Radiation Therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapy | Q24811929 | ||
| Toxicity and response criteria of the Eastern Cooperative Oncology Group | Q29619399 | ||
| Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapy | Q33385648 | ||
| Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature | Q33502056 | ||
| Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases | Q34059726 | ||
| Surgical treatment of liver metastases | Q34598612 | ||
| Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy. | Q34620919 | ||
| Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis | Q34874473 | ||
| Yttrium-90 radioembolization for colorectal cancer liver metastases: a single institution experience | Q35687650 | ||
| The blood supply of neoplasms in the liver | Q35930392 | ||
| Technical considerations in percutaneous hepatic perfusion--a multi-center experience | Q36374590 | ||
| Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics. | Q36600763 | ||
| Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 3: comprehensive literature review and future direction. | Q36631298 | ||
| Percutaneous catheter placement for hepatic arterial infusion chemotherapy | Q36990910 | ||
| Hepatic arterial infusion of chemotherapy: the role of diagnostic and interventional radiology | Q37009633 | ||
| Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases | Q37227126 | ||
| Repeated transarterial chemoembolization in the treatment of liver metastases of colorectal cancer: prospective study | Q37353563 | ||
| Chemotherapy with targeted agents for the treatment of metastatic colorectal cancer | Q37467967 | ||
| Liver metastases from colorectal cancer: radioembolization with systemic therapy | Q37626421 | ||
| State of the art: radiolabeled microspheres treatment for liver malignancies | Q37693928 | ||
| Role of intra-arterial hepatic chemotherapy in the treatment of colorectal cancer metastases | Q37821853 | ||
| Integrating radioembolization with chemotherapy in the treatment paradigm for unresectable colorectal liver metastases. | Q37833444 | ||
| Arterial therapies of colorectal cancer metastases to the liver | Q37890914 | ||
| Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study | Q39630468 | ||
| Incorporating cone-beam CT into the treatment planning for yttrium-90 radioembolization | Q39880101 | ||
| Utility of C-arm CT in patients with hepatocellular carcinoma undergoing transhepatic arterial chemoembolization | Q39918259 | ||
| Development of new hepaticoenteric collateral pathways after hepatic arterial skeletonization in preparation for yttrium-90 radioembolization. | Q39944651 | ||
| Embolization of parasitized extrahepatic arteries to reestablish intrahepatic arterial supply to tumors before yttrium-90 radioembolization | Q40001155 | ||
| Consolidation of hepatic arterial inflow by embolization of variant hepatic arteries in preparation for yttrium-90 radioembolization | Q40001165 | ||
| Trans-arterial chemoembolization of metastatic colorectal carcinoma to the liver adopting DC Bead®, drug-eluting bead loaded with irinotecan: results of a phase II clinical study. | Q40301411 | ||
| Selective chemoembolization in the management of hepatic metastases in refractory colorectal carcinoma: a phase II trial | Q40649086 | ||
| Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies | Q41479079 | ||
| Toxicity of irinotecan-eluting beads in the treatment of hepatic malignancies: results of a multi-institutional registry | Q42957008 | ||
| Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy | Q43010373 | ||
| Yttrium-90 microsphere-selective internal radiation therapy with chemotherapy (chemo-SIRT) for colorectal cancer liver metastases: an in vivo double-arm-controlled phase II trial | Q44539157 | ||
| Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer | Q45119871 | ||
| The significance of bremsstrahlung SPECT/CT after yttrium-90 radioembolization treatment in the prediction of extrahepatic side effects | Q45332662 | ||
| TACE of liver metastases from colorectal cancer adopting irinotecan-eluting beads: beneficial effect of palliative intra-arterial lidocaine and post-procedure supportive therapy on the control of side effects. | Q46100881 | ||
| Percutaneous hepatic perfusion in patients with metastatic liver cancer: anesthetic, hemodynamic, and metabolic considerations. | Q46818498 | ||
| 90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic im | Q46863439 | ||
| Selective internal radiation therapy with SIR-spheres for the treatment of unresectable colorectal hepatic metastases | Q50153921 | ||
| Radioembolization versus standard care of hepatic metastases: comparative retrospective cohort study of survival outcomes and adverse events in salvage patients | Q50176099 | ||
| Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. | Q51021204 | ||
| Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. | Q51043928 | ||
| Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. | Q51204089 | ||
| Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: preliminary results. | Q53513097 | ||
| Radiation pneumonitis after selective internal radiation treatment with intraarterial 90Yttrium-microspheres for inoperable hepatic tumors | Q71821807 | ||
| Colorectal metastases to the liver: selective chemoembolization | Q72534195 | ||
| The feasibility of retrograde catheterization of the right gastric artery via the left gastric artery | Q74459747 | ||
| Long-term survival of patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoinfusion | Q80982967 | ||
| Radioembolization in combination with systemic chemotherapy as first-line therapy for liver metastases from colorectal cancer | Q83939572 | ||
| Matched-pair comparison of radioembolization plus best supportive care versus best supportive care alone for chemotherapy refractory liver-dominant colorectal metastases | Q84617827 | ||
| Hepatic Intra-Arterial Injection of Drug-Eluting Bead, Irinotecan (DEBIRI) in Unresectable Colorectal Liver Metastases Refractory to Systemic Chemotherapy: Results of Multi-Institutional Study | Q84807162 | ||
| Chemoembolization of colorectal liver metastases with cisplatin, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol | Q85010584 | ||
| P433 | issue | 1 | |
| P921 | main subject | colorectal cancer | Q188874 |
| P304 | page(s) | 12-20 | |
| P577 | publication date | 2013-03-01 | |
| P1433 | published in | Seminars in interventional radiology | Q26842882 |
| P1476 | title | Intra-arterial therapies for metastatic colorectal cancer | |
| P478 | volume | 30 |
| Q35843666 | CT Perfusion Imaging Can Predict Patients' Survival and Early Response to Transarterial Chemo-Lipiodol Infusion for Liver Metastases from Colorectal Cancers |
| Q38831025 | Current strategies in interventional oncology of colorectal liver metastases |
| Q90634596 | Intra-arterial EmboCept S® and DC Bead® effectively inhibit tumor growth of colorectal rat liver metastases |
| Q47101871 | Intraarterial Liver-Directed Therapies: The Role of Interventional Oncology |
| Q38256165 | Liver-directed therapies in metastatic colorectal cancer |
| Q38398883 | Non-operative therapies for colorectal liver metastases |
| Q38551081 | Role of imaging for patients with colorectal hepatic metastases: what the radiologist needs to know |
| Q92150490 | The role of interventional oncology in the treatment of colorectal cancer liver metastases |
Search more.